CAS 61825-94-3
:Oxitiplatina
- Oxalato(trans-(-)-1,2-cyclohexanediamine)platinum(II)
- Platinum, [(1R,2R)-1,2-cyclohexanediamine-κN1,κN2][ethanedioato(2-)-κO1,κO2]-, (SP-4-2)-
- platinum(2+) ethanedioate (1R,2R)-cyclohexane-1,2-diamine (1:1)
- NSC-266046
- [SP-4-2-(IR-trans)]-(1,2-cyclohexanediamine-n,n')[ethanedioato(2-)-O,O']-platinum
- (1R,2R)-cyclohexane-1,2-diamine: oxalic acid: platinum(+2) cation
- xalatoplatinum
- (SP-4-2)-[(1R,2R)-1,2-Cyclohexanediamine-κN1,κN2][ethanedioato(2-)-κO1,κO2]platinum
- Platinum, [(1R,2R)-1,2-cyclohexanediamine-κN,κN′][ethanedioato(2-)-κO1,κO2]-, (SP-4-2)-
- latin
- cyclohexane-1,2-diamine: oxalic acid: platinum
- RP-54780
- (sp-4-2)-((1r,2r)-1,2-cyclohexanediamine-n,n')(ethanedioato(2-)-O,O']platinum
- Platinum, (1,2-cyclohexanediamine-N,N′)[ethanedioato(2-)-O,O′]-, [SP-4-2-(1R-trans)]-
- platinum(4+) cyclohexane-1,2-diyldiazanide ethanedioate (1:1:1)
- Elocatin
- Oxalipatin
- trans-L-Diaminocyclohexane oxalatoplatinum
- 1,2-Cyclohexanediamine, platinum complex, (1R-trans)-
- ι-OHP
- [SP-4-2-(1R-trans)]-(1，2-Cyclohexanediamine-N，N，)[ethanedioato(2-)-O，O’Jplatinum
- OXALIPLATIN
- OXALIPIATIN
- Lipoxal
- SP-4-2-(1R-TRANS)]-(1,2-CYCLOHEXANEDIAMINE-N,N)[ETHANEDIOATO(2-)-O,OPT
- Oxaliplatin(Eloxatin)
- NSC-266046：Elocatin
- Eloxatin
- Cis-[(1R,2R)-1,2-cyclothexanediammine-N,N`][oxalato(2-)-O,O`]platinum
- Oxalato[(1R-trans)-1,2-cyclohexanediamine]platinum(II)
- P-54780
- oxalatoplatinum
- [SP-4-2-(1R-TRANS)]-(1,2-CYCLOHEXANEDIAMINE-N,N')[ETHANEDIOATA(2-)-O,O']PLATINUM
- oxaliplatino
- Oxaliplatin (125 mg)
- platinuM(2+) ion (1R,2R)-cyclohexane-1,2-diaMine oxalate
- oxalatoplatin
- Oxaliplatin EP/BP
- (1R-trans)-1,2-Cyclohexanediamine, platinum complex
- [SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-N,N
- 1-ohp
- (1,2-cyclohexanediamine-n,n’)(ethanedioato(2-)-o,o’)-platinu(sp-4-2-(1r-tr
- OxaliplatinEp5
- Dacplat
- Elplat
- OXALIPLATIN (oxaliplatin)
- oxalato(1r,2r-cyclohexanediammine)platinum(ii)
- [SP-4-2-（1R-trans）]-(1,2-Cyclohexanediamine-N,Nˊ)[ethanedioato(2-)-O,Oˊ]platinum
- (trans-1,2-Cyclohexanediamine)oxalatoplatinum(II)
- Oxaliplatin99%
- Oxaliplatin API
- Ver mais sinónimos
Oxaliplatin
CAS:Fórmula:C8H14N2O4PtCor e Forma:White to Almost white powder to crystalPeso molecular:397.29Oxaliplatin
CAS:Inorganic or organic compounds of precious metals, whether or not chemically defined, or amalgams of precious metals, nesoiFórmula:C8H14N2O4PtCor e Forma:White Off-White PowderPeso molecular:397.06015Trans-L-Diaminocyclohexane Oxalatoplatinum
CAS:Fórmula:C8H14N2O4PtPureza:98%Cor e Forma:SolidPeso molecular:397.2858Oxaliplatin
CAS:Oxaliplatin (L-OHP) is a DNA alkylating agent, an inhibitor of DNA synthesis.Fórmula:C8H14N2O4PtPureza:97% - 99.93%Cor e Forma:SolidPeso molecular:397.29Oxaliplatin
CAS:Fórmula:C8H14N2O4PtPureza:98.0 - 102.0 % (dried basis)Cor e Forma:White to almost white crystalline powderPeso molecular:397.29Oxaliplatin
CAS:OxaliplatinFórmula:C8H14N2O4PtPureza:98%Cor e Forma: white solidPeso molecular:397.29g/molOxaliplatin
CAS:Produto ControladoFórmula:C8H14N2O4PtCor e Forma:White To Off-WhitePeso molecular:397.29Oxaliplatin
CAS:Produto ControladoApplications Third generation platinum complex. An antitumor agent with activity against colorectal cancer. Cytotoxicity follows the formation of adducts with DNA. Antineoplastic.
References Kidani, Y., et al.: J. Med. Chem., 21, 1315 (1978), Kizu, R., et al.: Cancer Chemother. Pharmacol., 31, 475 (1993), Levi, F., et al.: Eur. J. Cancer, 29A, 1280 (1993), Simpson, D., et al.: Drugs, 63, 2127 (2003),Fórmula:C8H14N2O4PtCor e Forma:White To Off-WhitePeso molecular:397.29Oxaliplatin - Bio-X ™
CAS:Oxaliplatin is a platinum-based DNA-cross-linking agent. It is a chemotherapeutic drug, often used in combination with leucovorin, fluorouracil, and capecitabine. Oxaliplatin works by cross-linking DNA thus inhibiting the synthesis of RNA and proteins, which leads to cell death and inhibition of cancer cells growth. It is more effective than cisplatin or irinotecan in treating metastatic cancer. Oxaliplatin also has effects on Toll-like receptor 4 (TLR4) expression levels in vitro and in vivo models. In addition, oxaliplatin's effect on ATP binding cassette transporter proteins may be responsible for its antitumour activity against solid tumours.
Oxaliplatin is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.Fórmula:C8H14N2O4PtPureza:Min. 98 Area-%Cor e Forma:White PowderPeso molecular:397.29 g/molOxaliplatin
CAS:Oxaliplatin is a platinum-based DNA-cross-linking agent. It is a chemotherapeutic drug, often used in combination with leucovorin, fluorouracil, and capecitabine. Oxaliplatin works by cross-linking DNA thus inhibiting the synthesis of RNA and proteins, which leads to cell death and inhibition of cancer cells growth. It is more effective than cisplatin or irinotecan in treating metastatic cancer. Oxaliplatin also has effects on Toll-like receptor 4 (TLR4) expression levels in vitro and in vivo models. In addition, oxaliplatin's effect on ATP binding cassette transporter proteins may be responsible for its antitumour activity against solid tumours.Fórmula:C8H14N2O4PtPureza:Min. 98 Area-%Cor e Forma:White Off-White PowderPeso molecular:397.29 g/mol
